• About
  • Partnerships
  • Challenges
  • Awards
  • Grant Opportunities
  • News

A New Platform for Vaccine Delivery Capable of Eliciting a Mucosal Immune Response

Daniel Stein and Phillip DeShong of the University of Maryland in the U.S. will construct and test a vaccine platform that utilizes low-cost, stable surfactant vesicles to deliver antigens for a sustained mucosal immune response. If successful, the platform could be used to develop low-cost vaccines for bacterial infections where carbohydrates form the basis of protective immunity, such as bacterial pneumonia and diarrheal diseases.

More information about Create New Ways to Protect Against Infectious Disease (Round 5)

Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

The Bill & Melinda Gates Foundation is part of the Grand Challenges partnership network. Visit www.grandchallenges.org to view the map of awarded grants across this network and grant opportunities from partners.